Detalhe da pesquisa
1.
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Exp Mol Pathol
; 135: 104882, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237798
2.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
3.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846246
4.
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
J Urol
; 193(6): 1905-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433306
5.
[Epidemiological study of dental and facial asymmetries in a sample of preschool subjects]. / Studio epidemiologico delle asimmetrie facciali e dentali in un campione di soggetti in età prescolare.
Epidemiol Prev
; 39(1): 45-51, 2015.
Artigo
em Italiano
| MEDLINE | ID: mdl-25855546
6.
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
Expert Rev Anticancer Ther
; 24(6): 347-361, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630549
7.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
8.
Immune-related gigantomastia: a case study.
Immunotherapy
; 15(13): 1001-1007, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431623
9.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010650
10.
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer.
Front Oncol
; 12: 886440, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712510
11.
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity.
Front Cardiovasc Med
; 9: 867867, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35498037
12.
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Front Oncol
; 12: 955501, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212433
13.
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases.
BJU Int
; 108(8 Pt 2): E250-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599821
14.
Second-line treatment in renal cell carcinoma: clinical experience and decision making.
Ther Adv Urol
; 13: 17562872211022870, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211586
15.
TIMP1 and TIMP2 Downregulate TGFß Induced Decidual-like Phenotype in Natural Killer Cells.
Cancers (Basel)
; 13(19)2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638439
16.
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA.
Front Oncol
; 11: 769158, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868998
17.
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Ther Adv Med Oncol
; 13: 17588359211019642, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046089
18.
The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review.
Front Oncol
; 10: 533, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457826
19.
Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.
Target Oncol
; 15(5): 691, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32857328
20.
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.
Target Oncol
; 15(4): 495-501, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671807